0 CHECKOUT

Iran Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3517977
  • December 2015
  • Region: Iran
  • 95 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • Darou Pakhsh
  • Exir Pharmaceuticals
  • Pars Darou
  • MORE

In light of easing economic sanctions, international drugmakers - both R&D-based and generic drug firms - will seek to gain a local presence in Iran's pharmaceutical market. Import restrictions mean supply opportunities will be very problematic for generic drugmakers without a local presence. The supply of patented drugs will be easier for multinationals, although a local presence will be the ideal scenario for most drugmakers.

Headline Expenditure Projections
- Pharmaceuticals: IRR60.70tn (USD2.35bn) in 2014 to IRR69.55trn (USD1.93bn) in 2015; +14.6% in local currency terms and -17.8% in US dollar terms. Forecast unchanged from previous quarter.

- Healthcare: IRR711.91trn (USD22.39bn) in 2014 to IRR819.73trn (USD22.77bn) in 2015; +15.1% in local currency terms and +1.7% in US dollar terms. Forecast slightly upgraded from previous quarter.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Darou Pakhsh
  • Exir Pharmaceuticals
  • Pars Darou
  • MORE

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Iran 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Iran 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Iran 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Iran 2011-2019)

Prescription Drug Market Forecast

Patented Drug Market Forecast

Generic Drug Market Forecast

OTC Market Forecast

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Iran 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Iran 2013-2019)

Key Risks To Forecast Scenario

Industry Risk/Reward Index

Middle East and Africa Risk/Reward Index - Q1 2016

Iran Risk/Reward Index

Rewards

Risks

Regulatory Review

Intellectual Property Regime

Counterfeit Medicines

Pricing And Reimbursement

Market Overview

Healthcare Sector
Table: Healthcare Resources (Iran 2009-2014)
Table: Healthcare Personnel (Iran 2009-2014)
Table: Healthcare Activity (Iran 2009-2014)

Healthcare Insurance

International Healthcare Collaboration

Traditional Herbal Remedies

Research & Development

Biotechnology

Clinical Trials

Epidemiology

Competitive Landscape

Pharmaceutical Sector

Generic Drugmakers
Table: Leading Drug Manufacturers, Iranian Year To March 20, 2009

Pharmaceutical Distribution
Table: Leading Distributors, Iranian Year To March 20 2008

Pharmaceutical Retail Sector
Table: Tehran Stock Exchange - Listed Pharmaceutical Companies As Of November 2015
Table: Multinational Company Activity

Company Profile

Caspian Tamin Pharmaceutical Company

Darou Pakhsh

Exir Pharmaceuticals

Pars Darou

Zahravi Pharmaceutical Company

Demographic Forecast
Table: Population Headline Indicators (Iran 1990-2025)
Table: Key Population Ratios (Iran 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Iran 1990-2025)
Table: Population By Age Group (Iran 1990-2025)
Table: Population By Age Group % (Iran 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

Caspian Tamin Pharmaceutical Company
Darou Pakhsh
Exir Pharmaceuticals
Pars Darou
Zahravi Pharmaceutical Company

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS from Cache

Our Clients

  • Pfizer Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S